INS and cancer: To address this gap, we evaluated prospective associations of HbA1c (an indicator of average blood glucose levels in the past 2 to 3 months) and c-peptide (an indicator of average insulin secretion in recent days/weeks) with the above-mentioned diabetes-associated cancers in a case-cohort study of 5,050 U.S. adults.